Articles published by Taysha Gene Therapies

Taysha Gene Therapies Added to the Nasdaq Biotechnology Index

December 15, 2021

From Taysha Gene Therapies

Via Business Wire

Tickers TSHA

Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 10, 2021

From Taysha Gene Therapies

Via Business Wire

Tickers TSHA

Taysha Gene Therapies Announces Publication of Positive Proof-of-Concept Preclinical Data for an AAV-mediated UBE3A Gene Replacement Approach Demonstrating Therapeutic Potential for The Treatment of Angelman Syndrome in the Journal JCI Insight

October 25, 2021

From Taysha Gene Therapies

Via Business Wire

Tickers TSHA

Taysha Announces Exclusive Option from UTSW to License Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program for CLN7 Disease, a Research Collaboration with UTSW to Develop Next-Generation Construct for CLN7 and a Grant Award to Batten Hope

October 05, 2021

From Taysha Gene Therapies

Via Business Wire

Tickers TSHA

Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

August 16, 2021

From Taysha Gene Therapies

Via Business Wire

Tickers TSHA

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.